Therapeutics and Diagnostics

Available biotechnologies may also be downloaded here.

in vivo data availabletarget validated in vivo

 

Title Tech ID #

Anti-CD79 Antibody Offers Novel Approach to Therapy in Autoimmune Disease, Transplantation and Lymphomain vivo data available

 11-15
PTPN13: A Novel Target for the Treatment of Pulmonary Fibrosisin vivo data available 11-09
Novel PIM 1 Kinase Inhibitor that Upregulates RUNX3 for the Treatment of Allergic Diseasesin vivo data available 11-06
Novel Adjuvant for Increasing Effectiveness of Vaccinesin vivo data available 10-13
Use of the Listeria Monocytogenes p60 Polypeptide and Variants for Stimulating NK cellsin vivo data available 10-08
Targeting FgfR2b for the Treatment of Adult Lung Injury 09-20
SERCA2: Novel Target for the Treatment of Cystic Fibrosis 09-05
Targeting a Subset of B Cells to Treat Autoimmune Diseasesin vivo data available 09-03
Adenosine A2A Receptor:  A Prognosis Marker for Lung Cancer 08-11
Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo  in vivo data available 07-07
MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo in vivo data available 06-05
Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.) in vivo data available 04-08
Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseasesin vivo data available 04-05
Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancerin vivo data available 02-16
Liposomal clodronate as a therapy for autoimmune hemolytic anemiain vivo data available 02-07
High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway 02-05
Novel molecular targets for anti-inflammatory drug development:
- TALL-1: A member of the TNF gene family
- TALL-1 receptor (BCMA)
- TALL-1 and receptors 3D structure		 02-01
Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsivenessin vivo data available 01-01
Calcitonin Gene-Related Peptide For The Reduction Of Allergen-Induced Airway Hyperresponsivenessin vivo data available 00-14
Cdk6 as a marker for breast cancer 00-11
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs 00-05
Peptides offer strategies for novel immunosuppressants and anti-herpes agents 96-02
Method to Produce Monoclonal Antibodies to Human T-Cell Receptor Elements 91-02

 

Research Tools

View list of available Antibodies or Animal models.

 

Biomedical Devices

View list of available biomedical devices.

 

For more information, contact Emmanuel Hilaire at HilaireE@njhealth.org.

Connect with Us Online

Become our fan on facebook!   Subscribe to our YouTube channel!   Follow us on Twitter!   Subscribe to our News RSS feed.

eNewsletters and More

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our Faculty by Area of Research.